ReviewCardiovascular therapeutics2022

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9-A Narrative Review.

Iveta Merćep et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.